Nomograms predicting benefit after immunotherapy in oral bifidobacteria supplementation ICC patients: a retrospective study
The nomogram developed in this study demonstrated favorable performance in predicting the prognosis of ICC patients undergoing immunotherapy. Additionally, our findings, for the first time, identified probiotics as a potential prognostic marker for immunotherapy. This prognostic model has the potential to enhance patient selection for immunotherapy and improve clinical decision-making.
Authors
- Sihui Zhu
- Chao Chen (ORCID: https://orcid.org/0000-0002-4476-4366)
- Jie Shen (ORCID: https://orcid.org/0000-0003-0680-3333)
- Minzheng Zhou
- Xiufeng Liu (ORCID: https://orcid.org/0000-0003-3888-0333)
- Juan Zhang (ORCID: https://orcid.org/0000-0001-7225-362X)
- Baorui Liu
- Yuncheng Jin
Institutions
- Nanjing General Hospital of Nanjing Military Command (CN)
- Nanjing Drum Tower Hospital (CN)
- Jiangsu Cancer Hospital (CN)
- Nanjing Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1186/s12885-024-12982-4
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jiangsu Commission of Health
- Nanjing University of Chinese Medicine
- Nanjing University
- National Health Commission of the People's Republic of China